AUTHOR=Bibert Stéphanie , Bratschi Martin W. , Aboagye Samuel Y. , Collinet Emilie , Scherr Nicole , Yeboah-Manu Dorothy , Beuret Christian , Pluschke Gerd , Bochud Pierre-Yves 

TITLE=Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms

JOURNAL=Frontiers in Microbiology

VOLUME=8

YEAR=2017

URL=https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2017.01903

DOI=10.3389/fmicb.2017.01903

ISSN=1664-302X

ABSTRACT=<p>Buruli ulcer (BU) is a chronic necrotizing disease of the skin and subcutaneous fat tissue. The causative agent, <italic>Mycobacterium ulcerans</italic>, produces mycolactone, a macrolide toxin, which causes apoptosis of mammalian cells. Only a small proportion of individuals exposed to <italic>M. ulcerans</italic> develop clinical disease, as surrounding macrophages may control the infection by bacterial killing at an early stage, while mycolactone concentration is still low. Otherwise, bacterial multiplication leads to in higher concentrations of mycolactone, with formation of necrotizing lesions that are no more accessible to immune cells. By typing a cohort of 96 Ghanaian BU patients and 384 endemic controls without BU, we show an association between BU and single nucleotide polymorphisms (SNPs) in <italic>iNOS</italic> (rs9282799) and <italic>IFNG</italic> (rs2069705). Both polymorphisms influence promoter activity <italic>in vitro</italic>. A previously reported SNP in <italic>SLC11A1</italic> (<italic>NRAMP</italic>, rs17235409) tended to be associated with BU. Altogether, these data reflect the importance of IFNG signaling in early defense against <italic>M. ulcerans</italic> infection.</p>